Icon

AMMONUL (nda020645)- (10%;10% (5GM/50ML;5GM/50ML))

SODIUM BENZOATE; SODIUM PHENYLACETATE BAUSCH
10%;10% (5GM/50ML;5GM/50ML)
No No
Expired Expired
2012-Feb-17 None
None No
AMMONUL is indicated as adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.
3 0 3
Total Other Developers None
Drugs with Suitability Yes
10%;10% (5GM/50ML;5GM/50ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* *** ********** ** **** *************** *********** *** * ***** *** ***** *** ****, **** ****, **** (**) *****, ****** ****** (***) ***
****** **** ****** *** ***** ****** ******* *********** ****** **. *** - ***, *** & ***, **** ************* ***** *****, *. *. *****, ******** ****, ******** - ************* ******, ******* - ********** ********, *********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.